In what continues to be an ongoing saga, the insider buying continues to swamp insider selling week in and week out. In fact, we have seen some of the lowest insider selling volumes over the past week that we have seen in almost three years. That remains a testament to the fact that insiders at companies feel that the stock they own is too cheap to sell now, and the see more upside down the road as 2015 rolls on.

We cover insider selling every week at 24/7 Wall St., and we like to always remind our readers that just because an individual or 10% institutional owner is selling stock, that is no cause for immediate alarm. Many top executives, and even directors, are compensated with stock, and often sell just to diversify or purchase other assets.

Here are companies that reported insider selling this past week.

Cheniere Energy Inc. (NYSE: LNG) has been a solid performing stock this year, and the CEO continues to sell shares. Charif Souki sold a 100,000 share block of the stock at prices that ranged from $51.93 to $56.00. The total for the sale came to $5.5 million. Cheniere Energy is an energy company that engages in the liquefied natural gas related business. The stock was trading on Friday at $52.65.

ALSO READ: 4 Safe High-Yield Dividend Stocks to Buy for Ongoing Volatility

United Health Inc. (NYSE: UNH) had a director at the health care company selling shares this past week. That director sold a total of 50,000 shares of the stock at prices that ranged from $117.40 to $117.85. The total for the sale came to a sizable $5.9 million. The stock was trading Friday at $122.37, so some serious cash was left on the table.

China Biologic Products Inc. (NASDAQ: CBPO) had numerous top executives selling stock last week. The chief financial officer, a senior vice president and a vice president at the company all parted with shares. The three sold a combined total of 23,050 shares at prices between $97.08 and $99.29 apiece. The total for the sales came to a tidy $2.3 million. The company engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People’s Republic of China. The shares were trading on Friday at $96.70.

Concert Pharmaceuticals Inc. (NASDAQ: CNCE) had a director at the company shed shares this past week. That director sold a total of 120,000 shares of the stock at prices between $18.00 and $18.72. The total for the sale came to $2.2 million. This a clinical stage biopharmaceutical company discovers and develops small molecule drugs for central nervous system disorders, genetic diseases, renal disease, inflammatory disease and cancer. The stock was trading Friday at $19.46, so some money left on the table here as well.

Century Communities Inc. (NYSE: CCS) had the CEO at the company sell some shares last week. Robert Francescon parted with a total of 100,000 shares at prices that ranged from $22.30 to $22.50 per share. The total of the sales came to $2.2 million. Century Communities engages in the homebuilding business in Atlanta, Central Texas, Colorado, Houston and Nevada. It is involved in the acquisition, entitlement and development of land, as well as the construction, marketing and sale of single-family attached and detached homes, townhomes and flats. The stock was trading on Friday at $23.38, so yet another trade where some significant money stayed on the table.

ALSO READ: History Says Market Could Retest Lows: 4 Safe Stocks to Buy

These companies also reported notable insider selling this week: Marriott International Inc. (NYSE: MAR) and OSI Systems Inc. (NASDAQ: OSIS).

The weekly low volume of sales continues to portend a favorable final quarter of 2015. When insiders aren’t selling stock, that is a very bullish sign for the markets. While volatility remains heightened, and probably will until the Federal Reserve finally lifts rates, the road forward does look promising

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.